"The Ear Institute of Texas is committed to serving those entrusted to our care by providing the latest advancements in medical technology to improve your quality of life. We are concerned about your whole hearing health and the effects it has on your connections with others. We strive to unite and educate those with and without hearing loss."

During the past decade, Ear Institute of Texas conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ear Institute of Texas" are "Acute Fungal Otitis Externa" (1 trials), "Acute Otitis Externa" (1 trials) and "High Frequency Sensorineural Hearing Loss" (1 trials). Many other conditions were trialed in "Ear Institute of Texas" in a lesser frequency.

Most popular intervention types in "Ear Institute of Texas" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "FST-201 (dexamethasone 0.1%) Otic Suspension" (2 trials), "Nucleus Hybrid L24 Implant" (1 trials), "Vehicle" (1 trials) and "ciprofloxacin 0.3%, dexamethasone 0.1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ear Institute of Texas" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ear Institute of Texas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ear Institute of Texas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ear Institute of Texas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".